Related Experiment Video
Updated: Jan 4, 2026

07:08
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.3K
Adjuvant EBRT improves survival in patients with lymph-node-negative pancreatic cancer
Lisa J Hazard1, Jonathan D Tward, Dennis C Shrieve
1Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah School of Medicine, Salt Lake City, UT 84112-5560, USA. lisa.hazard@hci.utah.edu
Nature Clinical Practice. Oncology
|June 26, 2008
Abstract
No abstract available in PubMed .

